[1] |
HE Lihua, ZHU Xiuzhi, JIANG Yizhou.
Research progress on immunotherapy for triple-negative breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 842-853.
|
[2] |
FU Xiaoyu, KONG Deguang, LI Juanjuan.
Treatment progress of triple positive breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 866-875.
|
[3] |
SHI Dawei, ZHENG Xiaoyong, JIN Xiaodan, ZHAO Xiaoman, CHEN Jie, DU Xingjun.
Implication of XPC rs2228001 polymorphism on the prognosis of patients with colorectal cancer who were treated with capecitabine-based adjuvant chemotherapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 391-399.
|
[4] |
WEI Zhenzhen, SUI Hua, JIANG Yulang, SUN Mingyu, YAN Huaru, WANG Ziyuan.
Research on the molecular mechanism of Zuo Jin Wan combined with cetuximab inducing ferroptosis in KRAS mutant colorectal cancer cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 130-137.
|
[5] |
MA A'xue, LU Xiaohong, DONG Bo, WANG Dong.
Research progress of exosomal miRNA in skin wound healing and regeneration
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 919-924.
|
[6] |
LI Miao, YU Qinwei, JIANG Zhenzhou, ZHANG Luyong, .
Regulatory mechanism of LDLR and research progress of its related diseases and drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 946-954.
|
[7] |
LIU Yanzhi, WANG Yan, LIU Kaili, ZHOU Wenhua, ZHU Ping, WANG Yingli, DU Shouying.
Inhibition and mechanism of Xihuang pill on mice bearing hepatoma H22 tumor
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 754-761.
|
[8] |
WU Shuai, YANG Jun, ZHENG Yun.
Dual role of miRNA in breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 814-821.
|
[9] |
DING Hao, GAO Zhenhua, ZHENG Yun.
Research progress of microRNA in diagnosis and treatment of prostate cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 696-708.
|
[10] |
LI Yanyan, FANG Xiaojie, YIN Xin, SUN Xi, RAO Chunhui.
circZNF124 regulates the proliferation, migration and invasion of colorectal cancer SW620 cells by targeting miR-4262
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1231-1239.
|
[11] |
DENG Ying, BAI Shutong.
Research advance of chrysoeriol on its pharmacological action and underlying mechnism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1155-1162.
|
[12] |
PENG Jing, SONG Jing, LUAN Jiajie.
Mesenchymal Stem Cells: a new discovery in the treatment of novel coronavirus pneumonia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1073-1079.
|
[13] |
HAO Haiping.
Metabolic regulation and drug target discovery researches in China: Progress and prospect
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 955-963.
|
[14] |
LU Qiong, ZHU Haihong, QI Tingting, LI Guohua, TENG Xinqi, QU Qiang, QU Jian.
OCTN2 gene polymorphisms affect the chemotherapeutic sensitivity of oxaliplatin in colorectal cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 401-407.
|
[15] |
YANG Huan, SHI Yuhong, RAN Haifeng, CHEN Yijin, XU Xiaoyu.
Erythropoietin's biological function and source
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 434-443.
|